G-CSF for Unexplained Recurrent Miscarriage During IVF
Part of Women’s health & pregnancy clinical trials.
This study tests whether G-CSF (a medicine that helps the immune system) given during IVF can reduce miscarriages in women who have had repeated pregnancy losses with no clear reason.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 44 years old.
- You have had at least 2 miscarriages with no known cause.
- You are having IVF and will test your embryos for normal chromosomes.
- Your body mass index (BMI) is between 19 and 35.
- You do not have any known chromosome problems, uterine issues, autoimmune disease, or blood clotting disorder.
- You have not used G-CSF before and are not allergic to it or E. coli proteins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called prednisolone can help prevent further miscarriages in people who have had recurrent miscarriages with no known cause. If you qualify, you would take prednisolone early in pregnancy and the study team would watch whether more losses occur.
This trial tests whether a drug called thymosin-α1 can help women who have had two or more failed embryo transfers with genetically normal embryos. It aims to improve the chances of successful implantation.
This study tests a medicine called G-CSF (given as an injection) to see if it helps improve egg quality and IVF success in women with a lower egg supply (diminished ovarian reserve). If you are between 35 and 44 and have been told your egg count is low but not too low, this might be worth exploring.
This study looks at immune-related blood patterns and other measurements to better understand why some women have repeated pregnancy loss or repeated IVF implantation failure. If you qualify, your answers and test results may help researchers identify biomarkers that could guide future care.
This study tests embryos before pregnancy using genetic screening to look for extra or missing chromosomes, in people who have had repeated IVF embryo transfers without success. It may help reduce the chance of transferring embryos that are unlikely to result in a healthy pregnancy.
This study tests whether giving a growth factor solution directly into the womb before embryo transfer can help thicken a thin uterine lining, which may improve the chance of a successful pregnancy. If you've had trouble with a thin lining, this treatment might help.
Hear when a new Recurrent Pregnancy Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.